Results for tag: "Small Cell Lung Cancer Drug"

Small Cell Lung Cancer (SCLC) is a type of lung cancer that is characterized by the rapid growth of malignant cells. It is the most aggressive form of lung cancer and accounts for approximately 10-15% of all lung cancer cases. Treatment for SCLC typically involves a combination of chemotherapy, radiation therapy, and surgery. Drugs used to treat SCLC include chemotherapy agents such as cisplatin, etoposide, and carboplatin, as well as targeted therapies such as erlotinib and gefitinib. Immunotherapy is also being explored as a potential treatment option. The SCLC drug market is highly competitive, with a number of companies developing and marketing drugs for the treatment of SCLC. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more